A randomized phase II study adding axitinib to pemetrexed-cisplatin in patients with malignant pleural mesothelioma (MPM): Clinical results of a single-center trial.
Wieneke A. Buikhuisen
No relevant relationships to disclose
Andrew D. Vincent
No relevant relationships to disclose
Marion M. Scharpfenecker
No relevant relationships to disclose
Catharina M. Korse
No relevant relationships to disclose
Arjan W. Griffioen
No relevant relationships to disclose
Renee van Pel
No relevant relationships to disclose
Paul Baas
No relevant relationships to disclose